These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16193639)

  • 1. Proportion of CD4+CD25+ regulatory T cell is increased in the patients with ovarian carcinoma.
    Li X; Ye DF; Xie X; Chen HZ; Lu WG
    Cancer Invest; 2005; 23(5):399-403. PubMed ID: 16193639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human ovarian carcinoma cells generate CD4(+)CD25(+) regulatory T cells from peripheral CD4(+)CD25(-) T cells through secreting TGF-beta.
    Li X; Ye F; Chen H; Lu W; Wan X; Xie X
    Cancer Lett; 2007 Aug; 253(1):144-53. PubMed ID: 17353088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance.
    Bamias A; Tsiatas ML; Kafantari E; Liakou C; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Tsitsilonis O; Bamia C; Papatheodoridis G; Politi E; Archimandritis A; Antsaklis A; Dimopoulos MA
    Gynecol Oncol; 2007 Jul; 106(1):75-81. PubMed ID: 17433425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The frequency, phenotypes and functions of CD4+ CD25+ regulatory T cells in hepatocellular carcinoma patients].
    Zhang HH; Fei R; Mei MH; Liao WJ; Wang XY; Cong X; Qin LL; Ji Y; Wang SX; Wei L; Chen HS
    Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):266-72. PubMed ID: 17456313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells.
    Unitt E; Rushbrook SM; Marshall A; Davies S; Gibbs P; Morris LS; Coleman N; Alexander GJ
    Hepatology; 2005 Apr; 41(4):722-30. PubMed ID: 15791620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Without prior stimulation, tumor-associated lymphocytes from malignant effusions lyse autologous tumor cells in the presence of bispecific antibody HEA125xOKT3.
    Strauss G; Gückel B; Wallwiener D; Moldenhauer G
    Clin Cancer Res; 1999 Jan; 5(1):171-80. PubMed ID: 9918216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast.
    Leong PP; Mohammad R; Ibrahim N; Ithnin H; Abdullah M; Davis WC; Seow HF
    Immunol Lett; 2006 Feb; 102(2):229-36. PubMed ID: 16246429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased population of CD4(+)CD25(high), regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients.
    Wang X; Zheng J; Liu J; Yao J; He Y; Li X; Yu J; Yang J; Liu Z; Huang S
    Eur J Haematol; 2005 Dec; 75(6):468-76. PubMed ID: 16313258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.
    Bamias A; Koutsoukou V; Terpos E; Tsiatas ML; Liakos C; Tsitsilonis O; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Papatheodoridis G; Archimandritis A; Antsaklis A; Dimopoulos MA
    Gynecol Oncol; 2008 Feb; 108(2):421-7. PubMed ID: 18036640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma.
    Siddiqui SA; Frigola X; Bonne-Annee S; Mercader M; Kuntz SM; Krambeck AE; Sengupta S; Dong H; Cheville JC; Lohse CM; Krco CJ; Webster WS; Leibovich BC; Blute ML; Knutson KL; Kwon ED
    Clin Cancer Res; 2007 Apr; 13(7):2075-81. PubMed ID: 17404089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of high mobility group box-1 protein on the correlation between regulatory T cells and CD4+ CD25- T cells of spleen in mice].
    Zhang Y; Yao YM; Yu Y; Wu Y; Sheng ZY
    Zhonghua Wai Ke Za Zhi; 2008 Feb; 46(3):217-20. PubMed ID: 18683721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer.
    Okita R; Saeki T; Takashima S; Yamaguchi Y; Toge T
    Oncol Rep; 2005 Nov; 14(5):1269-73. PubMed ID: 16211295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Foxp3+CD4+CD25+ regulatory T cells and Th1/Th2, Tc1/Tc2 profiles in the peripheral blood of patients with condyloma acuminatum.
    Xu Y; Zhu KJ; Zhu N; Jiang DH; Chen XZ; Cheng H
    Clin Exp Dermatol; 2009 Mar; 34(2):229-35. PubMed ID: 19077104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic features of tumor-infiltrating lymphocytes and peripheral blood lymphocytes in ovarian cancer patients.
    Schöndorf T; Engel H; Kurbacher CM; Brenne U; Kolhagen H; Göhring UJ; Scharl A; Mallmann P
    J Soc Gynecol Investig; 1998; 5(2):102-7. PubMed ID: 9509389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship of levels of CD4(+)CD25(+) regulatory T cells and expression of Foxp3 mRNA in peripheral blood with serum immunoglobulin E level in children with bronchiolitis].
    Zhu YF; Zhu JY; Li WW; Lan CF; Fang J; Lin HL
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 May; 11(5):349-53. PubMed ID: 19470254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of CD4+ CD25+ regulatory T cells in peripheral blood and salivary gland of patients with primary Sjögren's syndrome].
    Li XM; Li XP; Qian L; Wang GS; Zhang H; Zhei ZM; Li Q; Chen K; Wang XQ; Wang YP
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1034-6. PubMed ID: 17672966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus.
    Lee JH; Wang LC; Lin YT; Yang YH; Lin DT; Chiang BL
    Immunology; 2006 Feb; 117(2):280-6. PubMed ID: 16423064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased CD4CD25+FOXP3+ regulatory T Cells in cancer patients from conversion of CD4+CD25- T cells through tumor-derived factors.
    Mao C; Wang S; Jiang Q; Tong J; Ma J; Yang M; Xu X; Qiu G; Shao Q; Li L; Xu H
    Onkologie; 2008 May; 31(5):243-8. PubMed ID: 18497513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of circulating CD4+CD25+ T cells in myasthenia gravis patients with stability and thymectomy.
    Sun Y; Qiao J; Lu CZ; Zhao CB; Zhu XM; Xiao BG
    Clin Immunol; 2004 Sep; 112(3):284-9. PubMed ID: 15308122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of CD4+CD25high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer.
    Kawaida H; Kono K; Takahashi A; Sugai H; Mimura K; Miyagawa N; Omata H; Ooi A; Fujii H
    J Surg Res; 2005 Mar; 124(1):151-7. PubMed ID: 15734494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.